SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-062930
Filing Date
2023-05-22
Accepted
2023-05-22 07:45:27
Documents
14
Period of Report
2023-05-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316322d2_8k.htm   iXBRL 8-K 32310
2 EXHIBIT 99.1 tm2316322d2_ex99-1.htm EX-99.1 9260
6 GRAPHIC tm2316322d2_ex99-1img001.jpg GRAPHIC 3607
  Complete submission text file 0001104659-23-062930.txt   230809

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20230519.xsd EX-101.SCH 3072
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20230519_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20230519_pre.xml EX-101.PRE 22621
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2316322d2_8k_htm.xml XML 3826
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 23942452
SIC: 2834 Pharmaceutical Preparations